Key terms
About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AVXL news
Yesterday
8:46am ET
Largest borrow rate increases among liquid names
Mar 20
8:46am ET
Largest borrow rate increases among liquid names
Mar 18
7:35am ET
Anavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71
Feb 27
12:35pm ET
SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors
Feb 15
6:30am ET
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL), PolyPid (PYPD) and Nyxoah (NYXH)
Feb 09
8:45am ET
Largest borrow rate increases among liquid names
Feb 07
11:55am ET
Buy Rating Affirmed for Anavex Life Sciences Amid Positive Alzheimer’s Program Outlook and Financial Stability
Feb 07
7:33am ET
Anavex reports Q1 EPS (11c) vs. (17c) last year.
Jan 25
8:45am ET
Largest borrow rate increases among liquid names
Jan 24
7:37am ET
Anavex reports publication of ANAVEX 3-71 human study in clinical journal
Jan 23
8:45am ET
Largest borrow rate increases among liquid names
Jan 22
2:45pm ET
Anavex call volume above normal and directionally bullish
Jan 22
12:50pm ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Definitive Healthcare Corp (DH), Anavex Life Sciences (AVXL) and Inari Medical (NARI)
Jan 08
7:53am ET
Anavex announces grant of U.S. patent covering blarcamesine
Jan 05
11:01am ET
Biotech Alert: Searches spiking for these stocks today
Jan 04
11:13am ET
Biotech Alert: Searches spiking for these stocks today
Jan 03
8:35am ET
Maintaining Buy on Anavex: A Balanced View Amid Clinical Trial Setbacks and Future Potential
Jan 03
8:31am ET
Anavex price target lowered to $40 from $54 at H.C. Wainwright
Jan 02
9:27am ET
Maintaining Buy on Anavex: Setback in Rett Syndrome Trial Offset by Alzheimer’s Focus and Upcoming European Filing
Jan 02
8:12am ET
Anavex provides update on Rett Syndrome Program
No recent news articles are available for AVXL
Today
8:00am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL
Yesterday
2:33pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Yesterday
1:01pm ET
SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
Mar 27
6:09pm ET
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 27
2:32pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 26
5:54pm ET
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 26
2:31pm ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 25
2:30pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 23
8:43am ET
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 22
10:15pm ET
AVXL INVESTOR ALERT: Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 22
2:33pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 21
9:30pm ET
SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
Mar 21
2:32pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 21
9:44am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL
Mar 21
4:00am ET
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 20
5:39pm ET
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 20
2:31pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 19
2:31pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 18
2:30pm ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 17
8:47am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 15
11:13am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Mar 15
9:10am ET
SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
Mar 14
10:48am ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
Mar 14
9:07am ET
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 14
7:28am ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the Firm
AVXL Financials
Key terms
Ad Feedback
AVXL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AVXL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range